Document is current
Any future updates will be listed below
-
Authors
Taddei, Irene
Cirotti, Claudia
Lamballe, Fabienne
Castellanet, Olivier
Maina, Flavio
Medici, Vanessa
Fierro, Fabrizio
Corleone, Giacomo
De Nicola, Francesca
Fanciulli, Maurizio
Cesari, Eleonora
Di Leone, Alba
Piermattei, Alessia
Santoro, Angela
Naro, Chiara
Sette, Claudio
Barilà, Daniela
-
Funding
Funding for this research was provided by:
Ministero dell'Università e della Ricerca (MUR fellowship to the PhD Program in Cellular and Molecular Biology, University of Tor Vergata)
Associazione Italiana per la Ricerca sul Cancro (IG30651)
Associazione Italiana per la Ricerca sul Cancro (AIRC-IG2021-n.26230)
- License Information
-
More Information
Article History
Received: 5 December 2025
Accepted: 21 December 2025
First Online: 20 January 2026
Declarations
:
: For organoid development, tumor biopsies were collected from patients treated at ‘‘Fondazione Policlinico Universitario A. Gemelli IRCCS’’ (FPG), Rome, Italy, from May 2020 to October 2022. The protocol was approved by the Institutional Review Board (Protocol ID: 3642) and conducted in accordance with the Helsinki Declaration. All enrolled patients gave their written informed consent for participation. Relevant clinical data were collected and managed using REDCap electronic data capture tools at FPG ( ).
: Not applicable.
: The authors declare no competing interests.
